Access Bio Past Earnings Performance
Past criteria checks 0/6
Access Bio has been growing earnings at an average annual rate of 37.4%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 43% per year.
Key information
37.4%
Earnings growth rate
37.7%
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 43.0% |
| Return on equity | -0.9% |
| Net Margin | -0.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Access Bio makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 348,643 | -3,173 | 130,257 | 16,081 |
| 30 Sep 23 | 362,449 | 6,978 | 152,727 | 17,350 |
| 30 Jun 23 | 371,791 | -2,032 | 162,330 | 15,464 |
| 31 Mar 23 | 452,094 | 99,507 | 166,713 | 9,878 |
| 31 Dec 22 | 1,033,863 | 346,670 | 342,471 | 7,316 |
| 30 Sep 22 | 1,205,808 | 418,017 | 374,550 | 6,125 |
| 30 Jun 22 | 1,234,194 | 452,910 | 365,152 | 5,739 |
| 31 Mar 22 | 1,103,446 | 356,212 | 373,215 | 5,277 |
| 31 Dec 21 | 505,112 | 189,690 | 130,370 | 4,894 |
| 30 Sep 21 | 374,187 | 168,034 | 76,186 | 4,371 |
| 30 Jun 21 | 344,042 | 151,256 | 70,551 | 4,278 |
| 31 Mar 21 | 338,051 | 171,593 | 33,031 | 4,284 |
| 31 Dec 20 | 121,797 | 48,272 | 18,914 | 4,006 |
| 30 Sep 20 | 40,472 | -230 | 13,811 | 3,188 |
| 30 Jun 20 | 42,118 | -14,567 | 19,092 | 2,950 |
| 31 Mar 20 | 42,755 | -17,218 | 18,908 | 2,536 |
| 31 Dec 19 | 43,059 | -17,588 | 18,283 | 2,200 |
| 30 Sep 19 | 41,675 | -18,984 | 18,546 | 2,394 |
| 30 Jun 19 | 38,944 | -7,134 | 13,188 | 2,326 |
| 31 Mar 19 | 39,874 | -5,226 | 14,877 | 2,646 |
| 31 Dec 18 | 40,239 | -4,241 | 15,545 | 2,934 |
| 30 Sep 18 | 40,283 | -4,477 | 14,606 | 2,458 |
| 30 Jun 18 | 40,535 | -4,941 | 15,189 | 2,564 |
| 31 Mar 18 | 34,392 | -5,460 | 13,141 | 2,370 |
| 31 Dec 17 | 29,465 | -6,486 | 12,730 | 1,942 |
| 30 Sep 17 | 27,348 | -4,511 | 12,872 | 2,041 |
| 30 Jun 17 | 25,438 | -3,408 | 12,288 | 1,745 |
| 31 Mar 17 | 29,884 | -1,643 | 12,579 | 1,498 |
| 31 Dec 16 | 32,486 | 304 | 12,418 | 1,510 |
| 30 Sep 16 | 33,689 | 1,794 | 11,782 | 1,351 |
| 30 Jun 16 | 32,211 | 2,457 | 11,058 | 1,311 |
| 31 Mar 16 | 33,062 | 2,012 | 10,462 | 1,090 |
| 31 Dec 15 | 35,583 | 1,265 | 9,935 | 971 |
| 30 Sep 15 | 30,492 | 620 | 9,682 | 967 |
| 30 Jun 15 | 32,669 | 243 | 9,288 | 896 |
| 31 Mar 15 | 32,734 | 1,199 | 9,532 | 828 |
| 31 Dec 14 | 32,305 | 2,432 | 12,106 | 815 |
| 30 Sep 14 | 42,489 | 5,307 | 12,985 | 797 |
| 30 Jun 14 | 45,126 | 7,611 | 13,493 | 655 |
| 31 Mar 14 | 46,874 | 8,101 | 13,494 | 566 |
| 31 Dec 13 | 45,840 | 7,838 | 11,838 | 415 |
| 30 Sep 13 | 39,905 | 6,394 | 10,286 | 360 |
| 30 Jun 13 | 39,255 | 8,380 | 12,325 | 460 |
Quality Earnings: A950130 is currently unprofitable.
Growing Profit Margin: A950130 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A950130 is unprofitable, but has reduced losses over the past 5 years at a rate of 37.4% per year.
Accelerating Growth: Unable to compare A950130's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A950130 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.8%).
Return on Equity
High ROE: A950130 has a negative Return on Equity (-0.9%), as it is currently unprofitable.